TITLE

PORTRAIT OF A PREPARED SELLER

AUTHOR(S)
Weirens, Jeffery M.
PUB. DATE
December 2010
SOURCE
Business Finance;Winter2010, Vol. 16 Issue 4, p22
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the challenges for a chief financial officer (CFO) when a corporate decides on a divestiture. It notes that in the merger and acquisition, the CFO who fails to prepare properly for a carve-out may cost his company and their shareholders a huge amount of money. It tells that in a thorough preparation, the seller understands the intrinsic value of the deal from the buyer's perspective. It says that a CFO should be wary of loss of scale and a keen focus on controlling costs.
ACCESSION #
57275904

 

Related Articles

  • RSA: only looking after its own health.  // MarketWatch: Global Round-up;June 2003, Vol. 2 Issue 6, p83 

    Reports on Royal & Sun Alliance's (RSA) completion of the disposal of its British Healthcare and Assistance business to Oxfordway in a management buyout. Financial terms of the deal; Plan to expand the products and capabilities of the business; Plan of RSA to continue to underwrite the business...

  • Mergers & Acquisitions. Simpson, Wayne A. // Enterprise/Salt Lake City;5/8/2006, Vol. 35 Issue 44, p6 

    The author discusses issues related to the sale of business enterprises. He argues that deciding whether to sell a business enterprise is a difficult one and raises several questions on the part of a business owner. The reasons for selling a business as well as the reasons not to sell are also...

  • SDC Worldwide Mergers & Acquisitions.  // Mergers & Acquisitions Report;6/21/2004, Vol. 17 Issue 25, p7 

    Provides information on several worldwide mergers and acquisitions as of June 21, 2004. Summary of U.S. public merger activity greater than $50 million; Private targets greater than $50 million; Divestitures greater than $50 million.

  • Cardinal Plans To Sell Large Unit. J. R. C. // Mergers & Acquisitions Report;12/11/2006, Vol. 19 Issue 47, p5 

    This article reports on the plan of Cardinal Health Inc. to sell its Pharmaceutical Technologies and Services (PTS) unit. The unit contributes to a little over 10% of the company's revenue. Cardinal Health will keep the Martindale and Beckloff Associates operations within PTS. Chief Financial...

  • LUBRIZOL TO SELL DRUG INGREDIENTS BIZ. Bennett, David // Crain's Cleveland Business;4/3/2006, Vol. 27 Issue 14, p1 

    The article reports on the sale of Lubrizol Corp.'s pharmaceutical ingredient and compounds business, to a German private equity firm. Terms weren't disclosed. It would be the fifth divestiture since Wickliffe-based Lubrizol announced its intent to sell noncore businesses.

  • UCB Dumps 50+ Programs in $667M Deal with GSK.  // BioWorld Today;1/26/2009, Vol. 20 Issue 15, p2 

    The article reports on the decision of UCB SA to divest its smaller business operations, reaching a deal to sell more than 50 such programs to GlaxoSmithKline PLC for 515 million euro. Included in the acquisition deal are UCB operations in the Far East, Middle East, Latin America and Africa. UCB...

  • Degussa Puts Food Ingredients Business Up for Sale. Alperowicz, Natasha // Chemical Week;10/20/2004, Vol. 166 Issue 34, p19 

    Reports on the plan of Degussa to sell its food ingredients business. Reason for selling Degussa's food ingredient business; Businesses and entities that comprise the food ingredients operation; Efforts made by Degussa to expand its food ingredient business; Potential buyers of the business.

  • HOW TO SELL YOUR BUSINESS. Chantiri, Emily; Mills, Kate; King, Agnes; Lindhe, Jane // BRW;9/16/2010, Vol. 32 Issue 36, p20 

    The article offers pieces of advice on how to sell a business. It discusses the challenges facing business owners looking to sell their companies, and suggests that the greater number of stakeholders involved in the sale, the longer the sale could take. The article emphasizes the need for...

  • Akzo Nobel divestments.  // Process Engineering;May2004, Vol. 85 Issue 5, p5 

    Reports on the divestment move of Akzo Nobel NV. Sale of the company's two divisions; Opening of a new research and development laboratory; Completion of the divestment process; Benefits gained by Albermarle from the acquisition.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics